Springer-Lyle News Updates

latest legal news from the law firm of Springer-Lyle

1807 Westminster
Denton, TX 76205

940.387.0404

  • Home
  • About Us
    • Firm Overview
    • Attorney Profiles
  • Areas of Practice
  • Articles and Cases
  • What’s In the News
  • Resources
  • Videos
    • Who is Springer-Lyle?
    • FAQ Videos
      • FAQs on Business Litigation
      • FAQs on Healthcare, Medical & Pharmaceutical Cases
      • FAQs on Personal Injury, Automobile & Trucking Accidents
      • FAQs on Alternative Dispute Resolution
      • FAQs on Probate Cases
  • Contact Us
You are here: Home / Blog Articles / Health / Pharmaceutical Cases / Johnson & Johnson insulin cartridge recall

Johnson & Johnson insulin cartridge recall

March 15, 2011 By admin Leave a Comment

from Reuters

J&J Animas unit recalls leaky insulin cartridges

* 384,180 cartridges recalled in U.S., France

* 22 adverse events reported, no deaths

* Leak could result in underdelivery of insulin

* FDA also warns Cordis unit over stent manufacturing

* Shares close up 0.5 percent (Updates number of adverse events, closing share price)

By Bill Berkrot

NEW YORK, March 8 (Reuters) – Johnson & Johnson (JNJ.N), which has been beset by a seemingly endless stream of product recalls, has recalled hundreds of thousands of potentially leaky insulin pump cartridges that could lead to serious health problems and death.

It also has been warned by the U.S. Food and Drug Administration over manufacturing concerns for heart devices made at its Cordis unit’s San German, Puerto Rico, facility.

J&J’s Animas unit, the maker of the recalled cartridges and insulin pumps in which they are used by diabetics, said in a letter to patients last month that it found some of the cartridges can leak, resulting in delivery of less insulin than intended.

Insufficient insulin can cause high blood sugar and a serious condition known as diabetic ketoacidosis, which can be fatal. A leaking cartridge could also cause the pump to fail to sound an alarm if there were blockage in the infusion set, Animas said.

There have been reports of 22 adverse events experienced by patients, but none involved hospitalization or death, Animas spokeswoman Caroline Pavis told Reuters.

A total of 384,180 2.0 milliliter insulin cartridges were recalled. They came from from five lots shipped in the United States and one in France between Nov. 30 and Jan. 4, according to Pavis and a letter posted on the Animas website that listed the specific U.S. recalled lot numbers.

Animas first learned of the problem through complaints from customers about insulin leaking from the plunger side of the cartridge, Pavis explained.

The total recall represents about 5 percent of yearly production, Pavis said.

In addition to sending letters about the potential problem to users of its pumps, Animas said it had informed physicians and the FDA about the recall.

Separately, the FDA warned J&J’s Cordis unit in a letter sent to the company on Feb. 16 about a failure to ensure that heart devices made at the Puerto Rico plant — such as stents used to prop open arteries — were manufactured with consistency.

Specifically, inspectors found that Cordis’ procedures did not prevent abnormal products or ensure that its devices met certain specifications, according the FDA’s letter, made public on Tuesday and posted on its website.

The FDA uncovered the problems when it inspected the plant in September and October. Although the company has since said it would take steps to address the issues, agency officials said in the letter that those steps either did not work or did not go far enough.

The FDA issues dozens of such warning letters a year, although most are resolved without further action. The agency, can, however, seek penalties such as injunctions or fines.

J&J’s once-golden reputation has been badly tarnished by manufacturing and quality control problems at its plants that have led to a series of recalls of widely used consumer healthcare medicines, such as Tylenol, Rolaids and Motrin, and of medical devices and other products, including syringes and sutures.

The recalls, especially those of more than 250 million bottles and packages of its consumer healthcare products, cost J&J nearly $1 billion in lost sales in 2010 and are likely to hit revenue and earnings again this year as the company works to return affected products to pharmacy and supermarket shelves.

Shares of J&J closed up 31 cents, or 0.5 percent, at $60.71 on the New York Stock Exchange. (Reporting by Bill Berkrot; Additional reporting by Susan Heavey in Washington; Editing by Tim Dobbyn, Gerald E. McCormick and Matthew Lewis)

Filed Under: Pharmaceutical Cases, Recalls Tagged With: Accident, Animas, Attorney, consumers, Cordis, Denton, diabetic ketoacidosis, Doctor, FDA, Food and Drug Administration, Hazard, Injury, insulin cartridges, Johnson & Johnson, Lawyers, leaky insulin cartridges, leaky insulin pump cartridges, Patient, Personal Injury, Physical Injury, Recall, Safety, Texas, U.S. Consumer Product Safety Commission, Voluntary Recall, Wrongful Death

Leave a Reply Cancel reply

You must be logged in to post a comment.

Subscribe by email

Have the latest news from Springer-Lyle
sent to your inbox.

Articles of Interest

Honda Worldwide Recall of Sedans, Minivans, SUVs

By Deepa Seetharaman and Bernie Woodall of Reuters. Honda Motor Co Ltd plans to recall nearly 2 1/2 million vehicles: small SUVs, cars and minivans worldwide. This includes the popular Accord sedan. … [Read More…]

Hip Implant Complaints Increase, While Dangers Are Reviewed

By BARRY MEIER and JANET ROBERTS of the New York Times Published: August 22, 2011 The federal government has received a surge in complaints in recent months about failed hip replacements, suggesting … [Read More…]

Tragedy Brought on by Tainted Fruit

By Moni Basu, CNN William Beach was one of those people who fixated on certain foods. He would eat the same thing voraciously for a few days, and then, when he tired of the same tastes, he moved onto … [Read More…]

No Better Care, Thanks to Tort Reform

Published in The Texas Tribune by guest columnist, Charles M. Silver In 2006, Dr. Howard Marcus wrote that Texas’ 2003 tort reform statute sparked an “amazing turnaround” in which doctors came … [Read More…]

Springer & Lyle, LLP

1807 Westminster
Denton, TX 76205

phone: 940.387.0404
toll-free: 855.387.0404
fax: 940.383.7656

Disclaimer
The contents of this website does not imply legal advise or counsel and does not establish an attorney/client relationship. Please contact us for information on our policies regarding any relationship with clients, potential clients, or non-clients of our firm.

  • Facebook
  • RSS
  • Twitter
  • YouTube

 

 

make a Pament via LawPay

Return To Top of Page

Copyright © 2023 Springer & Lyle, L.L.P. • • • All Rights Reserved

Website Design by The Crouch Group

Log in